GLSI实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers...

Stats
今日成交量	27 889.00
平均成交量	52 203.00
市值	168.96M
EPS	$0 ( 2024-03-29 )
下一个收益日期	( $-0.200 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-19.01
ATR14	$0.170 (1.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Patel Snehal	Buy	3 000	Common Stock
2024-03-22	Patel Snehal	Buy	2 500	Common Stock
2024-03-20	Patel Snehal	Buy	1 500	Common Stock
2024-03-05	Patel Snehal	Buy	30 500	Common Stock
2024-03-04	Patel Snehal	Buy	4 100	Common Stock

INSIDER POWER
100.00
Last 96 transactions
Buy: 968 139 \| Sell: 271 338

音量相关性

長: -0.13 (neutral)

短: 0.94 (very strong)

Signal:(56.048) Expect same movement, but be aware

Greenwich LifeSciences, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Greenwich LifeSciences, 相关性 - 货币/商品

0.06
( neutral )

0.13
( neutral )

0.00
( neutral )

0.11
( neutral )

-0.16
( neutral )

0.46
( neutral )

Greenwich LifeSciences, 财务报表

Annual	2023
营收:	$0
毛利润:	$-3 612.00 (0.00 %)
EPS:	$-0.690

FY	2023
营收:	$0
毛利润:	$-3 612.00 (0.00 %)
EPS:	$-0.690

FY	2022
营收:	$0
毛利润:	$-3 612.00 (0.00 %)
EPS:	$-0.590

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.520

Financial Reports:

No articles found.

Greenwich LifeSciences,

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.